Novo Nordisk says China court upholds its semaglutide patent
Novo Nordisk said China’s Supreme People’s Court has upheld the validity of its semaglutide compound patent, according to a company statement issued on Saturday. China’s Supreme People’s Court thereby confirmed …
Novo Nordisk says China court upholds its semaglutide patent Read More
